Jinling Pharmaceutical Company Limited (SHE:000919)
China flag China · Delayed Price · Currency is CNY
7.54
-0.01 (-0.13%)
Feb 27, 2026, 3:04 PM CST

SHE:000919 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
4,6894,1044,0233,9663,8563,876
Market Cap Growth
15.49%2.02%1.43%2.86%-0.52%5.34%
Enterprise Value
3,3752,6443,5033,0763,1562,918
Last Close Price
7.546.497.647.457.237.16
PE Ratio
145.44101.5637.8837.6731.9659.50
Forward PE
-20.2420.2420.2420.2420.24
PS Ratio
1.501.251.261.491.371.55
PB Ratio
0.970.850.911.091.091.13
P/TBV Ratio
1.381.211.471.461.391.47
P/FCF Ratio
27.78---29.83193.24
P/OCF Ratio
17.0426.6218.9715.2213.2012.44
PEG Ratio
-1.011.011.011.011.01
EV/Sales Ratio
1.080.811.101.151.121.17
EV/EBITDA Ratio
24.0215.6215.2417.7210.849.94
EV/EBIT Ratio
-104.4843.3360.2818.6516.80
EV/FCF Ratio
19.99---24.42145.51
Debt / Equity Ratio
0.040.040.010.000.01-
Debt / EBITDA Ratio
1.351.080.180.030.06-
Debt / FCF Ratio
1.13---0.13-
Net Debt / Equity Ratio
-0.49-0.51-0.47-0.50-0.42-0.38
Net Debt / EBITDA Ratio
-17.64-14.49-9.04-10.55-5.11-4.49
Net Debt / FCF Ratio
-14.0451.7180.3637.35-11.50-65.67
Asset Turnover
0.550.570.640.590.640.59
Inventory Turnover
9.829.529.458.649.468.64
Quick Ratio
3.403.252.692.722.372.27
Current Ratio
3.693.522.983.042.672.56
Return on Equity (ROE)
0.15%0.39%3.20%3.18%4.39%2.73%
Return on Assets (ROA)
-0.07%0.27%1.01%0.71%2.42%2.57%
Return on Invested Capital (ROIC)
-0.09%0.48%3.40%2.37%6.35%6.56%
Return on Capital Employed (ROCE)
-0.10%0.50%1.80%1.40%4.70%5.00%
Earnings Yield
0.68%0.98%2.64%2.66%3.13%1.68%
FCF Yield
3.60%-1.16%-0.64%-1.24%3.35%0.52%
Dividend Yield
1.33%1.54%1.31%1.34%1.38%1.40%
Payout Ratio
220.46%156.50%48.17%48.60%42.00%138.60%
Buyback Yield / Dilution
-9.53%-17.56%-0.01%0.02%0.01%-0.02%
Total Shareholder Return
-8.23%-16.02%1.30%1.36%1.40%1.38%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.